During the past decade, Labib Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Labib Medical Center" are "Complicated Intra-abdominal Infections" (1 trials), "Complicated Urinary Tract Infection" (1 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Lupus Nephritis" (1 trials). Many other conditions were trialed in "Labib Medical Center" in a lesser frequency.

Most popular intervention types in "Labib Medical Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Imipenem/Cilastatin" (1 trials), "NXL104/ceftazidime" (1 trials), "Phosphate-buffered saline" (1 trials), "abetimus sodium (LJP 394)" (1 trials) and "abetimus sodium (LJP 394) and/or placebo solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Labib Medical Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Labib Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Labib Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Labib Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".